Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

MetroMD The HGH Clinic Announces A Better Process of Reducing Aging
  • USA - English


News provided by

MetroMD

Oct 10, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


(PRWEB) October 10, 2014 -- MetroMD, a leading anti-aging clinic of Los Angeles, is making waves in Los Angeles with its flagship anti-aging treatments like PRP and HGH therapy. Platelet Rich Plasma or PRP Therapy and Human Growth Hormone or HGH Therapy is the two anti-aging treatment concepts introduced by MetroMD which have taken the wellness world by storm.Platelet Rich Plasma or PRP Therapy and Human Growth Hormone or HGH Therapy is the two anti-aging treatment concepts introduced by MetroMD which have taken the wellness world by storm.

All these treatments are associated with concepts of youngevity and longevity, giving its patients a chance to live a highly active and healthy middle age and old age filled with fun and vigor of youth.

Post this

Human growth hormone is a protein based peptide hormone secreted naturally in humans by the pituitary gland and is responsible for growth in children and adolescents. In adults, the growth hormones or HGH is responsible for cell reproduction, tissue regeneration and immune system functioning. It is also responsible for vitality, energy, metabolism and sexual performance in adults. After the age of 30, human HGH levels show a steady decline and after age of 40 the decline rate becomes rapid. This leads to feeling fatigued, low in energy levels, a loss in sexual libido and a weakened cardio-vascular system.

An HGH specialist at MetroMD elaborated “Permanent fatigue, weight gain, loss of lean muscle mass and lowered sexual performance as well as sexual arousals are all classic symptoms of aging and it simply means the body has started its shut-down mechanism. With research it has been found that the condition is caused because of growth hormone deficiencies in body. So the cure has to be one which returns the hormone levels to the youthful levels. One way is to stimulate pituitary gland to secrete optimum HGH again and the other treatment method is to artificially inject bio-synthetic HGH in the body to remove the deficiency. This second treatment method is what the clinic provides and it is known as the Human Growth Hormone Therapy or in short, HGH Therapy.

Growth hormone therapy has proven immensely beneficial to those who have undergone the treatment. Children, who had stunted growth, gained a near normal growth and adults who have undergone HGH Therapy have shown remarkable improvement in their body composition, physical strength and sexual performance. A 50+ male undergoing HGH replacement treatment for the last five months was exuberant in its praise “I felt energized from the day one. I no more feel that persisting fatigue and body pain and my libido shoots through the roof. Erectile deficiency was a thing of the past and I my abdominal fat just seems to melt away. I clearly gained lean muscle mass and my friends say I look 10 years younger now. I was skeptical earlier and thought I was trashing my money. But now I am a believer.”

In aging women, human HGH replacement counters weight-gain problem which affects a lot of women in their middle age. Like men, they too experience a dip in libido levels by age 35-40 which is returned to normal levels with treatment. Facial wrinkles are replaced with a firm youthful skin. Hair quality too improves and in many cases, the treatment causes reverse of graying and hair loss. In both men and women, this therapy causes strengthening of the immune system which translates into improved life expectancy.

MetroMD has been a pioneer in human growth hormone treatment in Los Angeles and has treated hundreds of highly satisfied HGH deficiency patients so far. The clinic’s clientele include big names from Hollywood, American Music Industry, Sports, Authors, Socialites, Professionals, Business World and other walks of life. Medical Director of MetroMD, Dr Alex Martin has been involved in growth hormone treatment and anti-aging regenerative medicine research since 70’s and in mid 90’s. He launched his anti-aging clinic in Newport Beach California. He was among the first to initiate Growth hormone treatment for children who had a stunted growth due to growth hormone deficiency. Like Dr Alex Martin, MetroMD’s Managing Director Devin Stone is also an expert in anti-aging treatment, stem cell research and regenerative medicine. MetroMD’s key treatments include Stem Cell Therapy, PRP therapy, Laser Treatments, Smartlipo and HGH Therapy. All these treatments are associated with concepts of longevity, giving its patients a chance to live a highly active and healthy middle age and old age filled with fun and vigor of youth.

Devin Stone, MetroMD, http://www.metromd.net, +1 323-285-5300, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.